Switch to:

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 8/10

vs
industry
vs
history
Cash to Debt No Debt
CSRMY's Cash to Debt is ranked higher than
93% of the 311 Companies
in the Global Medical Devices industry.

( Industry Median: 2.27 vs. CSRMY: No Debt )
CSRMY' s 10-Year Cash to Debt Range
Min: 0.18   Max: 18483
Current: No Debt

0.18
18483
Equity to Asset 0.83
CSRMY's Equity to Asset is ranked higher than
80% of the 282 Companies
in the Global Medical Devices industry.

( Industry Median: 0.65 vs. CSRMY: 0.83 )
CSRMY' s 10-Year Equity to Asset Range
Min: 0.43   Max: 0.83
Current: 0.83

0.43
0.83
Interest Coverage 19.19
CSRMY's Interest Coverage is ranked lower than
77% of the 161 Companies
in the Global Medical Devices industry.

( Industry Median: 10000.00 vs. CSRMY: 19.19 )
CSRMY' s 10-Year Interest Coverage Range
Min: 2.41   Max: 50.87
Current: 19.19

2.41
50.87
F-Score: 8
Z-Score: 13.20
WACC vs ROIC
1.82%
17.25%
WACC
ROIC
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 6/10

vs
industry
vs
history
Operating margin (%) 15.95
CSRMY's Operating margin (%) is ranked higher than
83% of the 294 Companies
in the Global Medical Devices industry.

( Industry Median: 3.51 vs. CSRMY: 15.95 )
CSRMY' s 10-Year Operating margin (%) Range
Min: 1.28   Max: 22.55
Current: 15.95

1.28
22.55
Net-margin (%) 12.94
CSRMY's Net-margin (%) is ranked higher than
84% of the 294 Companies
in the Global Medical Devices industry.

( Industry Median: 1.99 vs. CSRMY: 12.94 )
CSRMY' s 10-Year Net-margin (%) Range
Min: -22.63   Max: 25.45
Current: 12.94

-22.63
25.45
ROE (%) 11.61
CSRMY's ROE (%) is ranked higher than
76% of the 285 Companies
in the Global Medical Devices industry.

( Industry Median: 3.24 vs. CSRMY: 11.61 )
CSRMY' s 10-Year ROE (%) Range
Min: -33.01   Max: 25.77
Current: 11.61

-33.01
25.77
ROA (%) 9.15
CSRMY's ROA (%) is ranked higher than
84% of the 313 Companies
in the Global Medical Devices industry.

( Industry Median: -0.11 vs. CSRMY: 9.15 )
CSRMY' s 10-Year ROA (%) Range
Min: -21.16   Max: 14.87
Current: 9.15

-21.16
14.87
ROC (Joel Greenblatt) (%) 24.59
CSRMY's ROC (Joel Greenblatt) (%) is ranked higher than
75% of the 308 Companies
in the Global Medical Devices industry.

( Industry Median: 3.35 vs. CSRMY: 24.59 )
CSRMY' s 10-Year ROC (Joel Greenblatt) (%) Range
Min: 1.85   Max: 66.54
Current: 24.59

1.85
66.54
Revenue Growth (3Y)(%) -9.10
CSRMY's Revenue Growth (3Y)(%) is ranked lower than
81% of the 185 Companies
in the Global Medical Devices industry.

( Industry Median: 3.20 vs. CSRMY: -9.10 )
CSRMY' s 10-Year Revenue Growth (3Y)(%) Range
Min: -9.5   Max: 16.5
Current: -9.1

-9.5
16.5
EBITDA Growth (3Y)(%) -1.20
CSRMY's EBITDA Growth (3Y)(%) is ranked lower than
52% of the 155 Companies
in the Global Medical Devices industry.

( Industry Median: 0.90 vs. CSRMY: -1.20 )
CSRMY' s 10-Year EBITDA Growth (3Y)(%) Range
Min: -17.9   Max: 23.5
Current: -1.2

-17.9
23.5
EPS Growth (3Y)(%) 9.50
CSRMY's EPS Growth (3Y)(%) is ranked higher than
69% of the 160 Companies
in the Global Medical Devices industry.

( Industry Median: -4.90 vs. CSRMY: 9.50 )
CSRMY' s 10-Year EPS Growth (3Y)(%) Range
Min: -39.7   Max: 57.3
Current: 9.5

-39.7
57.3
» CSRMY's 10-Y Financials

Financials


Revenue & Net Income
Cash & Debt
Oprt. Cash Flow & Free Cash Flow

» Details

Insider Trades

Latest Guru Trades with CSRMY

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

No Entry found in the selected group of Gurus. You can
  • 1. Modify your Personalized List of Gurus, or
  • 2. Click on Premium Premium Tools above to check out all the Gurus, or
  • 3. Click on Premium Plus Premium Plus above for the stocks picks of all the institutional investment advisors (>4000)
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Ratios

vs
industry
vs
history
P/E(ttm) 21.40
CSRMY's P/E(ttm) is ranked higher than
64% of the 151 Companies
in the Global Medical Devices industry.

( Industry Median: 25.30 vs. CSRMY: 21.40 )
CSRMY' s 10-Year P/E(ttm) Range
Min: 8.01   Max: 65.49
Current: 21.4

8.01
65.49
Forward P/E 18.08
CSRMY's Forward P/E is ranked higher than
71% of the 105 Companies
in the Global Medical Devices industry.

( Industry Median: 22.03 vs. CSRMY: 18.08 )
N/A
PE(NRI) 20.30
CSRMY's PE(NRI) is ranked higher than
72% of the 149 Companies
in the Global Medical Devices industry.

( Industry Median: 28.80 vs. CSRMY: 20.30 )
CSRMY' s 10-Year PE(NRI) Range
Min: 11.07   Max: 61.86
Current: 20.3

11.07
61.86
P/B 3.80
CSRMY's P/B is ranked lower than
78% of the 269 Companies
in the Global Medical Devices industry.

( Industry Median: 2.55 vs. CSRMY: 3.80 )
CSRMY' s 10-Year P/B Range
Min: 1.27   Max: 3.8
Current: 3.8

1.27
3.8
P/S 2.80
CSRMY's P/S is ranked lower than
61% of the 266 Companies
in the Global Medical Devices industry.

( Industry Median: 2.18 vs. CSRMY: 2.80 )
CSRMY' s 10-Year P/S Range
Min: 0.65   Max: 2.9
Current: 2.8

0.65
2.9
POCF 19.91
CSRMY's POCF is ranked higher than
54% of the 153 Companies
in the Global Medical Devices industry.

( Industry Median: 20.43 vs. CSRMY: 19.91 )
CSRMY' s 10-Year POCF Range
Min: 4.71   Max: 55.07
Current: 19.91

4.71
55.07
EV-to-EBIT 24.89
CSRMY's EV-to-EBIT is ranked lower than
55% of the 165 Companies
in the Global Medical Devices industry.

( Industry Median: 22.45 vs. CSRMY: 24.89 )
CSRMY' s 10-Year EV-to-EBIT Range
Min: 7.9   Max: 29.8
Current: 24.89

7.9
29.8
PEG 8.12
CSRMY's PEG is ranked lower than
74% of the 53 Companies
in the Global Medical Devices industry.

( Industry Median: 3.07 vs. CSRMY: 8.12 )
CSRMY' s 10-Year PEG Range
Min: 0.57   Max: 96.63
Current: 8.12

0.57
96.63
Shiller P/E 20.60
CSRMY's Shiller P/E is ranked higher than
75% of the 93 Companies
in the Global Medical Devices industry.

( Industry Median: 24.60 vs. CSRMY: 20.60 )
CSRMY' s 10-Year Shiller P/E Range
Min: 12.07   Max: 69.59
Current: 20.6

12.07
69.59
Current Ratio 3.58
CSRMY's Current Ratio is ranked higher than
61% of the 308 Companies
in the Global Medical Devices industry.

( Industry Median: 2.48 vs. CSRMY: 3.58 )
CSRMY' s 10-Year Current Ratio Range
Min: 0.78   Max: 3.58
Current: 3.58

0.78
3.58
Quick Ratio 3.01
CSRMY's Quick Ratio is ranked higher than
65% of the 308 Companies
in the Global Medical Devices industry.

( Industry Median: 1.95 vs. CSRMY: 3.01 )
CSRMY' s 10-Year Quick Ratio Range
Min: 0.58   Max: 3.01
Current: 3.01

0.58
3.01
Days Inventory 167.95
CSRMY's Days Inventory is ranked lower than
64% of the 273 Companies
in the Global Medical Devices industry.

( Industry Median: 130.93 vs. CSRMY: 167.95 )
CSRMY' s 10-Year Days Inventory Range
Min: 164.13   Max: 212.47
Current: 167.95

164.13
212.47

Dividend & Buy Back

vs
industry
vs
history
Dividend Yield 9.50
CSRMY's Dividend Yield is ranked higher than
96% of the 109 Companies
in the Global Medical Devices industry.

( Industry Median: 0.00 vs. CSRMY: 9.50 )
CSRMY' s 10-Year Dividend Yield Range
Min: 1.92   Max: 5.73
Current: 9.5

1.92
5.73
Dividend Payout 2.25
CSRMY's Dividend Payout is ranked lower than
65% of the 95 Companies
in the Global Medical Devices industry.

( Industry Median: 0.31 vs. CSRMY: 2.25 )
CSRMY' s 10-Year Dividend Payout Range
Min: 0.14   Max: 1.97
Current: 2.25

0.14
1.97
Dividend growth (3y) 1.70
CSRMY's Dividend growth (3y) is ranked lower than
61% of the 46 Companies
in the Global Medical Devices industry.

( Industry Median: 3.60 vs. CSRMY: 1.70 )
CSRMY' s 10-Year Dividend growth (3y) Range
Min: 0   Max: 11.7
Current: 1.7

0
11.7
Yield on cost (5-Year) 10.54
CSRMY's Yield on cost (5-Year) is ranked higher than
96% of the 111 Companies
in the Global Medical Devices industry.

( Industry Median: 0.00 vs. CSRMY: 10.54 )
CSRMY' s 10-Year Yield on cost (5-Year) Range
Min: 2.13   Max: 6.36
Current: 10.54

2.13
6.36
Share Buyback Rate -0.20
CSRMY's Share Buyback Rate is ranked higher than
74% of the 175 Companies
in the Global Medical Devices industry.

( Industry Median: -2.80 vs. CSRMY: -0.20 )
CSRMY' s 10-Year Share Buyback Rate Range
Min: -0.1   Max: -2.2
Current: -0.2

Valuation & Return

vs
industry
vs
history
Price/Net Cash 500.00
CSRMY's Price/Net Cash is ranked lower than
146% of the 110 Companies
in the Global Medical Devices industry.

( Industry Median: 0.00 vs. CSRMY: 500.00 )
CSRMY' s 10-Year Price/Net Cash Range
Min: 385.75   Max: 385.75
Current: 500

Price/Net Current Asset Value 60.00
CSRMY's Price/Net Current Asset Value is ranked lower than
131% of the 157 Companies
in the Global Medical Devices industry.

( Industry Median: 9999.00 vs. CSRMY: 60.00 )
CSRMY' s 10-Year Price/Net Current Asset Value Range
Min: 6.65   Max: 127.15
Current: 60

6.65
127.15
Price/Tangible Book 5.00
CSRMY's Price/Tangible Book is ranked lower than
69% of the 249 Companies
in the Global Medical Devices industry.

( Industry Median: 3.10 vs. CSRMY: 5.00 )
CSRMY' s 10-Year Price/Tangible Book Range
Min: 1.25   Max: 25.28
Current: 5

1.25
25.28
Price/DCF (Projected) 2.00
CSRMY's Price/DCF (Projected) is ranked lower than
62% of the 114 Companies
in the Global Medical Devices industry.

( Industry Median: 1.60 vs. CSRMY: 2.00 )
CSRMY' s 10-Year Price/DCF (Projected) Range
Min: 0.6   Max: 4.64
Current: 2

0.6
4.64
Price/Median PS Value 2.00
CSRMY's Price/Median PS Value is ranked lower than
102% of the 269 Companies
in the Global Medical Devices industry.

( Industry Median: 1.00 vs. CSRMY: 2.00 )
CSRMY' s 10-Year Price/Median PS Value Range
Min: 0.5   Max: 1.61
Current: 2

0.5
1.61
Price/Graham Number 2.00
CSRMY's Price/Graham Number is ranked higher than
55% of the 141 Companies
in the Global Medical Devices industry.

( Industry Median: 2.50 vs. CSRMY: 2.00 )
CSRMY' s 10-Year Price/Graham Number Range
Min: 1.02   Max: 4.4
Current: 2

1.02
4.4
Earnings Yield (Greenblatt) 4.00
CSRMY's Earnings Yield (Greenblatt) is ranked higher than
70% of the 302 Companies
in the Global Medical Devices industry.

( Industry Median: 1.10 vs. CSRMY: 4.00 )
CSRMY' s 10-Year Earnings Yield (Greenblatt) Range
Min: 3.4   Max: 12.6
Current: 4

3.4
12.6
Forward Rate of Return (Yacktman) 4.12
CSRMY's Forward Rate of Return (Yacktman) is ranked higher than
53% of the 100 Companies
in the Global Medical Devices industry.

( Industry Median: 3.09 vs. CSRMY: 4.12 )
CSRMY' s 10-Year Forward Rate of Return (Yacktman) Range
Min: -11.9   Max: 20.4
Current: 4.12

-11.9
20.4

Analyst Estimate

Apr15 Apr16 Apr17 Apr18
Revenue(Mil) 256 418 405 194
EPS($) 0.66 0.80 0.91 1.09
EPS without NRI($) 0.66 0.80 0.91 1.09

Business Description

Industry: Medical Devices » Medical Devices
Compare: » details
Traded in other countries:CSRT.UK, CSRN.UK,
Consort Medical PLC was incorporated on March 22, 1946. The Company is engaged in the design, development and manufacture of specialty medical drug delivery devices and services to the pharmaceutical industry through its Bespak division. The Bespak develops and manufactures devices to deliver drugs to sufferers of asthma and COPD.

Personalized Checklist

Checklist has been moved to "Checklist" tab.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK